DRMA: Dermata Therapeutics, Inc. Stock

by  •  • Comments Off on DRMA: Dermata Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2.45
Enterprise Value ($M) -3.69
Book Value ($M) 4.74
Book Value / Share 2.32
Price / Book 0.52
NCAV ($M) 4.74
NCAV / Share 2.32
Price / NCAV 0.52

Profitability (mra)
Return on Invested Capital (ROIC) -2.38
Return on Assets (ROA) -1.41
Return on Equity (ROE) -1.77

Liquidity (mrq)
Quick Ratio 3.44
Current Ratio 3.44

Balance Sheet (mrq) ($M)
Current Assets 6.69
Assets 6.69
Liabilities 1.95
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
6 days ago 13G Intracoastal Capital, Llc
11-14 13G/A Armistice Capital, Llc 9.99 -54.82

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-31 51,401 134,003 38.36
2025-01-30 31,817 128,148 24.83
2025-01-29 21,860 119,630 18.27
2025-01-28 85,488 239,850 35.64

(click for more detail)

Similar Companies
DERM – Journey Medical Corporation DMAC – DiaMedica Therapeutics Inc.
DNTH – Dianthus Therapeutics, Inc. DRRX – DURECT Corporation
DRUG – Bright Minds Biosciences Inc.


Financial data and stock pages provided by
Fintel.io